Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
Jianxu Zhang,1,2,* Yudi Wang,2,* Jiawen Chen,2 Xiao Liang,2 Haobo Han,1,2 Yan Yang,2 Quanshun Li,1,2 Yanbo Wang1 1Department of Urology, First Hospital of Jilin University, 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University,...
Enregistré dans:
Auteurs principaux: | Zhang J, Wang Y, Chen J, Liang X, Han H, Yang Y, Li Q |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4cee84d2a3524cbe900ae36f6d0681be |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
par: Javad Khanali, et autres
Publié: (2021) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
par: Xia Y, et autres
Publié: (2017) -
D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming
par: Tan X, et autres
Publié: (2019) -
Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
par: Chen M, et autres
Publié: (2019) -
Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
par: Hemati M, et autres
Publié: (2019)